Resources Contact Us Home
Regulatory T cells and their use in immunotherapy and suppression of autoimmune responses

Image Number 17 for United States Patent #8129185.

Based upon a strong correlation between regulator T cells (Treg cells) and suppressing or preventing a cytotoxic T cell response, provided are methods for the production of ex vivo activated and culture-expanded isolated CD4.sup.+CD25.sup.+ suppressor Treg cells for the prevention or suppression of immune reactions in a host, particularly in a human host, and including autoimmune responses. The resulting ex vivo culture-expanded Treg cells provide a sufficient amount of otherwise low numbers of such cells, having long term suppressor capability to permit therapeutic uses, including the preventing, suppressing, blocking or inhibiting the rejection of transplanted tissue in a human or other animal host, or protecting against graft vs host disease. Also provided are therapeutic and immunosuppressive methods utilizing the ex vivo culture-expanded Treg cells for human treatment, and high efficiency methods for research use.

  Recently Added Patents
Identification of protected content in e-mail messages
Methods and apparatus for performing multiple photoresist layer development and etching processes
Power converter and method including noise suppression by controlling phase shifting of converter cells
Display screen with graphical user interface
Case for electronic device
Process for the preparation of protected L-alanine derivatives
Light barrier and method for detecting objects
  Randomly Featured Patents
Radio frequency identification reader
Golf ball dimple structures with vortex generators
Combustion-type power tool having switch protection arrangement
Method of manufacturing semiconductor device and semiconductor device
Package with a sliding lid
Television set
Waveform modulation system
Explosive blasting method and means
Utility motor vehicle with carrier
Method for checking an integrated electrical circuit